Vera Therapeutics Inc (VERA)

Feb 01, 2025

SG Americas Securities LLC Acquires 10,916 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat

Feb 01, 2025

Jan 31, 2025

The Goldman Sachs Group Begins Coverage on Vera Therapeutics (NASDAQ:VERA) - MarketBeat

Jan 31, 2025

Jan 30, 2025

Vera Therapeutics (NASDAQ:VERA) Stock Price Up 4.9%Here's Why - MarketBeat

Jan 30, 2025

Jan 30, 2025

The Goldman Sachs Group Initiates Coverage on Vera Therapeutics (NASDAQ:VERA) - Defense World

Jan 30, 2025

Jan 29, 2025

SG Americas Securities LLC Increases Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Jan 29, 2025

Jan 29, 2025

Trading (VERA) With Integrated Risk Controls - Stock Traders Daily

Jan 29, 2025

Jan 28, 2025

Vera started at buy by Goldman Sachs, atacicept potential cited - MSN

Jan 28, 2025

Jan 28, 2025

Vera Therapeutics (NASDAQ:VERA) Shares Gap UpHere's Why - MarketBeat

Jan 28, 2025

Jan 28, 2025

Goldman Sachs Initiates Vera Therapeutics at Buy With $58 Price Target -January 28, 2025 at 07:43 am EST - Marketscreener.com

Jan 28, 2025

Jan 27, 2025

Polycythemia Vera Pipeline 2024: Clinical Trials Overview, - openPR

Jan 27, 2025

Jan 24, 2025

Research Analysts Set Expectations for VERA FY2025 Earnings - Defense World

Jan 24, 2025

Jan 23, 2025

Cantor Fitzgerald Predicts VERA FY2025 Earnings - MarketBeat

Jan 23, 2025

Jan 22, 2025

Top 3 Health Care Stocks That Could Blast Off This Quarter - Benzinga

Jan 22, 2025

Jan 21, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Rating of “Buy” from Analysts - Defense World

Jan 21, 2025

Jan 20, 2025

Possible Bearish Signals With Vera Therapeutics Insiders Disposing Stock - Simply Wall St

Jan 20, 2025

Jan 20, 2025

Vera Therapeutics Releases Updated Corporate Presentation Following J.P. Morgan Healthcare Conference - Defense World

Jan 20, 2025

Jan 18, 2025

When the Price of (VERA) Talks, People Listen - Stock Traders Daily

Jan 18, 2025

Jan 17, 2025

JPMorgan Chase & Co. Decreases Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Jan 17, 2025

Jan 15, 2025

Nephrotic Syndrome Market Set to Grow Substantially Through 2034, DelveInsight Projects | GlaxoSmithKline, Goldfinch Bio, Inc., Travere Therapeutics, Inc., Aurinia Pharmaceuticals, Bristol-Myers Squib - The Globe and Mail

Jan 15, 2025

Jan 15, 2025

Vera Therapeutics Getting Closer To Key Technical Benchmark - MSN

Jan 15, 2025

Jan 15, 2025

Head to Head Comparison: CannTrust (OTCMKTS:CNTTF) versus Vera Therapeutics (NASDAQ:VERA) - Defense World

Jan 15, 2025

Jan 14, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jan 14, 2025

Jan 14, 2025

Vera Therapeutics Awards New Employee Stock Options and RSUs Worth $42.19 Per Share - StockTitan

Jan 14, 2025

Jan 14, 2025

Vera Therapeutics Stocks Surge Amid Strategic Moves - TipRanks

Jan 14, 2025

Jan 14, 2025

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down Following Insider Selling - Defense World

Jan 14, 2025

Jan 13, 2025

What's Going On With Vera Therapeutics Stock?Vera Therapeutics (NASDAQ:VERA) - Benzinga

Jan 13, 2025

Jan 13, 2025

Vera Therapeutics (NASDAQ:VERA) Shares Gap Down After Insider Selling - MarketBeat

Jan 13, 2025

Jan 13, 2025

Vera Therapeutics Highlights Atacicept Progress at Conference - TipRanks

Jan 13, 2025

Jan 13, 2025

Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

Vera Therapeutics Secures Stanford's Novel B Cell Therapy VT-109 in Exclusive Deal - StockTitan

Jan 13, 2025

Jan 11, 2025

Vera Therapeutics CEO Marshall sells shares for $730,535 By Investing.com - Investing.com Australia

Jan 11, 2025

Jan 10, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Marshall Fordyce Sells 17,500 Shares - MarketBeat

Jan 10, 2025

Jan 10, 2025

Vera Therapeutics (NASDAQ:VERA) Trading Down 7.3%Should You Sell? - MarketBeat

Jan 10, 2025

Jan 10, 2025

Vera Therapeutics CEO Marshall sells shares for $730,535 - Investing.com

Jan 10, 2025

Jan 08, 2025

Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025

Jan 07, 2025

How to Take Advantage of moves in (VERA) - Stock Traders Daily

Jan 07, 2025

Jan 07, 2025

Is Vera Therapeutics The NEXT BIG THING? Stock Price Soars! - Truth or Fiction

Jan 07, 2025

Jan 07, 2025

Vera Therapeutics to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 07, 2025

Jan 01, 2025

Franklin Resources Inc. Sells 5,859 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Jan 01, 2025

Dec 31, 2024

Certain Options of Vera Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2024. - Marketscreener.com

Dec 31, 2024

Dec 27, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Rating of "Buy" by Brokerages - MarketBeat

Dec 27, 2024

Dec 24, 2024

Geode Capital Management LLC Buys 20,223 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Dec 24, 2024

Dec 24, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) Position Boosted by Geode Capital Management LLC - MarketBeat

Dec 24, 2024

Dec 23, 2024

Barclays PLC Acquires 41,394 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat

Dec 23, 2024

Dec 22, 2024

Vera Therapeutics: Strong Data In IgAN, But We May Be Too Late (NASDAQ:VERA) - Seeking Alpha

Dec 22, 2024

Dec 20, 2024

Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells $753,725.00 in Stock - MarketBeat

Dec 20, 2024

Dec 20, 2024

Vera Therapeutics Insider Sold Shares Worth $753,680, According to a Recent SEC Filing - Marketscreener.com

Dec 20, 2024